Timeline

Mathieu Mateo
Permanent Researcher
01 Sep 2019
publication

Fatal Case of Lassa Fever, Bangolo District, Côte d’Ivoire, 2015

Read more
23 Mar 2019
publication

Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses

Read more
21 Mar 2019
publication

Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus

Read more
10 Jan 2019
publication

Immune parameters and outcomes during Ebola virus disease

Read more
12 Nov 2018
publication

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells

Read more
01 Oct 2018
publication

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

Read more
29 May 2018
publication

A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins

Read more
28 Sep 2017
publication

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs

Read more
15 Jun 2017
publication

Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea

Read more
23 Mar 2017
publication

Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea

Read more
23 Feb 2017
publication

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

Read more
14 Jan 2017
publication

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

Read more
18 Dec 2016
publication

Ocular Complications in Survivors of the Ebola Outbreak in Guinea

Read more
14 Nov 2016
publication

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies

Read more
03 May 2016
publication

New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors

Read more
05 Apr 2016
publication

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Read more
01 Mar 2016
publication

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Read more
07 Jan 2016
publication

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

Read more
16 Dec 2015
publication

[Viral zoonoses and emergence: research is just starting]

Read more
21 Jul 2015
publication

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement

Read more
19 Jul 2015
publication

Towards deep insight into Ebola virus disease

Read more
03 Jul 2015
project

Lassa fever

Read more
11 May 2015
team

Biology of Viral Emerging Infections

Read more
06 Feb 2015
publication

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

Read more
01 Jan 2015
publication

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Read more
24 Nov 2014
publication

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014

Read more
19 Nov 2014
publication

Ebola: should we consider influenza vaccination?

Read more
24 Sep 2014
publication

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

Read more
24 Sep 2014
publication

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Read more
16 Apr 2014
publication

Emergence of Zaire Ebola virus disease in Guinea

Read more
09 Jan 2014
publication

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

Read more
05 Nov 2012
publication

Immune responses and Lassa virus infection

Read more
01 Jul 2012
publication

NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression

Read more
31 Aug 2011
publication

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

Read more
01 Jun 2011
publication

Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus

Read more
09 Feb 2011
publication

Evidence for Ebola virus superantigen activity

Read more
05 Oct 2010
publication

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

Read more
01 Oct 2010
publication

Towards broad protection against Ebolaviruses

Read more
18 Mar 2009
publication

Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys

Read more
20 Mar 2006
publication

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages

Read more
01 Jul 2005
publication

A single shot against Ebola and Marburg virus

Read more
01 Oct 2004
publication

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

Read more
01 Mar 2004
publication

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

Read more
01 Dec 2003
publication

[Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates]

Read more